Saliva-based point-of-care assay to measure the concentration of pyrazinamide using a mobile UV spectrophotometer

Pyrazinamide, one of the first-line antituberculosis drugs, displays variability in drug exposure that is associated with treatment response. A simple, low-cost assay may be helpful to optimize treatment. This study aimed to develop and validate a point-of-care assay to quantify the concentration of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of antimicrobial chemotherapy Jg. 80; H. 1; S. 254
Hauptverfasser:	Chen, Ricky Hao, Nguyen, Thi Anh, Kim, Hannah Yejin, Stocker, Sophie L, Alffenaar, Jan-Willem C
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 03.01.2025
Schlagworte:	Adult Antitubercular Agents - analysis Drug Monitoring - methods Female Humans Male Point-of-Care Systems Pyrazinamide - analysis Reproducibility of Results Saliva - chemistry Sensitivity and Specificity Spectrophotometry, Ultraviolet - methods
ISSN:	1460-2091, 1460-2091
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!